C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia

被引:1
|
作者
Kortazar-Zubizarreta, Izaro [1 ]
Manero-Azua, Africa [2 ]
Afonso-Aguera, Juan [3 ]
Perez de Nanclares, Guiomar [2 ]
机构
[1] Araba Univ Hosp Txagorritxu, Bioaraba Hlth Res Inst, Dept Neurol, Vitoria 01009, Spain
[2] Araba Univ Hosp, Bioaraba Hlth Res Inst, Mol Epi Genet Lab, Vitoria 01009, Spain
[3] Hosp Univ Cent Asturias, Dept Neurol, Oviedo 33006, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 09期
关键词
C9ORF72; gene; frontotemporal dementia; amyotrophic lateral sclerosis; ALS-FTD; REPEAT EXPANSION; LOBAR DEGENERATION; RNA FOCI; ANTISENSE TRANSCRIPTS; MUTATIONS; ALS; NEUROPATHOLOGY; TOXICITY; FEATURES; TRANSLATION;
D O I
10.3390/jpm13091396
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The expanded GGGGCC hexanucleotide repeat (HRE) in the non-coding region of the C9ORF72 gene (C9ORF72-HRE) is the most common genetic cause of familial forms of amyotrophic lateral sclerosis (ALS), FTD, and concurrent ALS and FTD (ALS-FTD), in addition to contributing to the sporadic forms of these diseases. Both syndromes overlap not only genetically, but also sharing similar clinical and neuropathological findings, being considered as a spectrum. In this paper we describe the clinical-genetic findings in a Basque family with different manifestations within the spectrum, our difficulties in reaching the diagnosis, and a narrative review, carried out as a consequence, of the main features associated with C9ORF72-HRE. Family members underwent a detailed clinical assessment, neurological examination, and genetic analysis by repeat-primed PCR. We studied 10 relatives of a symptomatic carrier of the C9ORF72-HRE expansion. Two of them presented the expansion in the pathological range, one of them was symptomatic whereas the other one remained asymptomatic at 72 years. Given the great intrafamilial clinical variability of C9ORF72-HRE, the characterization of patients and family members with particular clinical and genetic subgroups within ALS and FTD becomes a bottleneck for medication development, in particular for genetically focused medicines for ALS and FTD.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
    Jie Jiang
    John Ravits
    Neurotherapeutics, 2019, 16 : 1115 - 1132
  • [32] Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
    Sattler, Rita
    Traynor, Bryan J.
    Robertson, Janice
    Van den Bosch, Ludo
    Barmada, Sami J.
    Svendsen, Clive N.
    Disney, Matthew D.
    Gendron, Tania F.
    Wong, Philip C.
    Turner, Martin R.
    Boxer, Adam
    Babu, Suma
    Benatar, Michael
    Kurnellas, Michael
    Rohrer, Jonathan D.
    Donnelly, Christopher J.
    Bustos, Lynette M.
    Van Keuren-Jensen, Kendall
    Dacks, Penny A.
    Sabbagh, Marwan N.
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1821 - 1843
  • [33] Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion
    Coon, Elizabeth A.
    Daube, Jasper R.
    Dejesus-Hernandez, Mariely
    Adeli, Anahita
    Savica, Rodolfo
    Parisi, Joseph E.
    Dickson, Dennis W.
    Josephs, Keith A.
    Baker, Matthew C.
    Johnson, Kris A.
    Ivnik, Robert J.
    Petersen, Ronald C.
    Knopman, David S.
    Boylan, Kevin B.
    Rademakers, Rosa
    Boeve, Bradley F.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (02) : 132 - 137
  • [34] Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
    Patel, Anjali N.
    Sampson, Jacinda B.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2015, 15 (09)
  • [35] C9orf72Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
    Shpilyukova, Yu. A.
    Fedotova, E. Yu.
    Abramycheva, N. Yu.
    Kochergin, I. A.
    Zakroyshchikova, I. V.
    Zakharova, M. N.
    Illarioshkin, S. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 169 (05) : 673 - 676
  • [36] Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features
    Mahoney, Colin J.
    Beck, Jon
    Rohrer, Jonathan D.
    Lashley, Tammaryn
    Mok, Kin
    Shakespeare, Tim
    Yeatman, Tom
    Warrington, Elizabeth K.
    Schott, Jonathan M.
    Fox, Nick C.
    Rossor, Martin N.
    Hardy, John
    Collinge, John
    Revesz, Tamas
    Mead, Simon
    Warren, Jason D.
    BRAIN, 2012, 135 : 736 - 750
  • [37] C9orf72 Hexanucleotide Repeat Expansions as the Causative Mutation for Chromosome 9p21-Linked Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Daoud, Hussein
    Suhail, Hamid
    Sabbagh, Mike
    Belzil, Veronique
    Szuto, Anna
    Dionne-Laporte, Alexandre
    Khoris, Jawad
    Camu, William
    Salachas, Francois
    Meininger, Vincent
    Mathieu, Jean
    Strong, Michael
    Dion, Patrick A.
    Rouleau, Guy A.
    ARCHIVES OF NEUROLOGY, 2012, 69 (09) : 1159 - 1163
  • [38] The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders
    Yang, Qijie
    Jiao, Bin
    Shen, Lu
    FRONTIERS IN GENETICS, 2020, 11
  • [39] Pathogenesis underlying hexanucleotide repeat expansions in C9orf72 gene in amyotrophic lateral sclerosis
    Chong, Zhao Zhong
    Menkes, Daniel L.
    Souayah, Nizar
    REVIEWS IN THE NEUROSCIENCES, 2024, 35 (01) : 85 - 97
  • [40] Hydroxymethylcytosine is an Epigenetic Regulator of the C9orf72 Hexanucleotide Repeat in Frototemporal Dementia and Amyotrophic Lateral Sclerosis
    Zeier, Zane
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 205S - 205S